Evidence of cytogenetic and molecular remission by allogeneic cells after immunosuppressive therapy alone-Reference-Cited by-同舟云学术

Evidence of cytogenetic and molecular remission by allogeneic cells after immunosuppressive therapy alone

Published:1998-11 Issue:2 Volume:103 Page:565-567
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Carella Angelo M.,Lerma Enrica,Corsetti Maria T.,Dejana Anna,Celesti Lidia,Casarino Lucia,De Stefano Francesco,Frassoni Francesco

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1998.01057.x/fullpdf

Reference4 articles.

1. Effective mobilization of Philadelphia-chromosome negative cells in chronic myelogenous leukaemia patients using a less intensive regimen.;Carella;British Journal of Haematology,1998

2. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft versus leukemia without myeloablative therapy.;Giralt;Blood,1997

3. Engraftment and induction of GvL with fludarabine (FAMP)-based non-ablative preparative regimen in patients with chronic lymphocytic leukemia (CLL) and lymphoma.;Khouri;Blood,1996

4. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.;Slavin;Blood,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT);European Journal of Haematology;2008-07-18

2. Reduced-Intensity Conditioning Allogeneic Blood Stem Cell Transplantation with Fludarabine and Oral Busulfan with or without Pharmacokinetically Targeted Busulfan Dosing in Patients with Myeloid Leukemia Ineligible for Conventional Conditioning;Biology of Blood and Marrow Transplantation;2005-06

3. Analysis of haematopoietic chimaerism by quantitative real-time polymerase chain reaction;Bone Marrow Transplantation;2004-11-08

4. Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy—from bench to patient bedside;Seminars in Oncology;2004-02

5. Long-Term Molecular Remission after Nonmyeloablative Stem Cell Transplantation in a Patient with Chronic Myelogenous Leukemia in the Chronic Phase;Acta Haematologica;2004